| Nanoparticles for radiation therapy enhancement: the key parameters P Retif, S Pinel, M Toussaint, C Frochot, R Chouikrat, T Bastogne, ... Theranostics 5 (9), 1030, 2015 | 365 | 2015 |
| Inorganic nanoparticles for photodynamic therapy L Colombeau, S Acherar, F Baros, P Arnoux, AM Gazzali, K Zaghdoudi, ... Light-responsive nanostructured systems for applications in nanomedicine …, 2016 | 63 | 2016 |
| Proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastoma M Toussaint, S Pinel, F Auger, N Durieux, M Thomassin, E Thomas, ... Theranostics 7 (2), 436, 2017 | 40 | 2017 |
| Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach H Benachour, T Bastogne, M Toussaint, Y Chemli, A Sève, C Frochot, ... PLoS One 7 (11), e48617, 2012 | 27 | 2012 |
| Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability TH Lai, M Toussaint, R Teodoro, S Dukić-Stefanović, D Gündel, ... European journal of nuclear medicine and molecular imaging 48, 2727-2736, 2021 | 17 | 2021 |
| Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A2B receptor M Lindemann, S Hinz, W Deuther-Conrad, V Namasivayam, ... Bioorganic & Medicinal Chemistry 26 (16), 4650-4663, 2018 | 17 | 2018 |
| PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [18F]FESCH Synthesized by a Simplified Two … S Schröder, TH Lai, M Toussaint, M Kranz, A Chovsepian, Q Shang, ... Molecules 25 (7), 1633, 2020 | 15 | 2020 |
| Synthesis and Biological Evaluation of a Novel 18F-Labeled Radiotracer for PET Imaging of the Adenosine A2A Receptor TH Lai, M Toussaint, R Teodoro, S Dukić-Stefanović, M Kranz, ... International Journal of Molecular Sciences 22 (3), 1182, 2021 | 10 | 2021 |
| Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET D Gundel, W Deuther-Conrad, L Ueberham, S Kaur, E Otikova, R Teodoro, ... Journal of Medicinal Chemistry 65 (13), 9034-9049, 2022 | 9 | 2022 |
| In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain S Dukić-Stefanović, TH Lai, M Toussaint, O Clauß, II Jevtić, JZ Penjišević, ... Bioorganic & Medicinal Chemistry Letters 48, 128254, 2021 | 9 | 2021 |
| Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain R Teodoro, D Gündel, W Deuther-Conrad, L Ueberham, M Toussaint, ... International Journal of Molecular Sciences 22 (15), 8051, 2021 | 9 | 2021 |
| Pathophysiological changes in the enteric nervous system of rotenone-exposed mice as early radiological markers for parkinson's disease G Schaffernicht, Q Shang, A Stievenard, K Bötzel, Y Dening, R Kempe, ... Frontiers in Neurology 12, 642604, 2021 | 9 | 2021 |
| Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery F Mitrach, M Schmid, M Toussaint, S Dukic-Stefanovic, W Deuther-Conrad, ... Pharmaceutics 14 (2), 326, 2022 | 8 | 2022 |
| Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand RP Moldovan, D Gündel, R Teodoro, FA Ludwig, S Fischer, M Toussaint, ... International Journal of Molecular Sciences 22 (11), 5447, 2021 | 6 | 2021 |
| Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine-based radioligand for the imaging of phosphodiesterase 2A with positron emission … R Ritawidya, B Wenzel, R Teodoro, M Toussaint, M Kranz, ... Molecules 24 (22), 4149, 2019 | 6 | 2019 |
| Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation TH Lai, S Schröder, M Toussaint, S Dukić-Stefanović, M Kranz, FA Ludwig, ... International Journal of Molecular Sciences 22 (5), 2285, 2021 | 5 | 2021 |
| Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[18F]Fluspidine in Glioblastoma M Toussaint, W Deuther-Conrad, M Kranz, S Fischer, FA Ludwig, ... Molecules 25 (9), 2170, 2020 | 5 | 2020 |
| Preclinical Incorporation Dosimetry of [18F]FACH—A Novel 18F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET B Sattler, M Kranz, B Wenzel, NT Jain, RP Moldovan, M Toussaint, ... Molecules 25 (9), 2024, 2020 | 5 | 2020 |
| Nanoparticles for radiation therapy enhancement: the key parameters. Theranostics 5 (9): 1030–1044 P Retif, S Pinel, M Toussaint, C Frochot, R Chouikrat, T Bastogne, ... | 5 | 2015 |
| Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells HA Saleh, N Mitwasi, M Ullrich, M Kubeil, M Toussaint, W Deuther-Conrad, ... Frontiers in Immunology 14, 1166169, 2023 | 4 | 2023 |
